Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356479 · ClinicalTrials.gov registry record · NA
Enhancing Mental and Physical Health of Women Veterans 3.0
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07356479: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07356479 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07356479, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Women Veterans are the fastest growing segment of VA users, with most users in midlife. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. Furthermore, few VA improvement efforts have focused on women Veterans' health and health care in midlife. The EMPOWER QUERI 3.0 Program is a cluster randomized type 3 hybrid implementation-effectiveness trial testing two strategies designed to support implementation and sustainment of evidence-based practices for women Veterans in at least 18 VA facilities from 4 regions.
Primary Outcome
\# of women with shared decision-making treatment planning marker (1=WBS completed in EHR)
Interventions
- BEHAVIORAL EBQI Booster (EBQI/B)
- BEHAVIORAL EBQI Booster + External Facilitation (EBQI/B+EF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2031-09-30 |
| Phase | NA |
What is known before NCT07356479 opens enrollment
NCT07356479 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which EBQI Booster (EBQI/B) is the first listed.
NCT07356479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07356479 about?
NCT07356479 is a clinical study titled "Enhancing Mental and Physical Health of Women Veterans 3.0". Women Veterans are the fastest growing segment of VA users, with most users in midlife. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. Furthermore, few VA i...
What is the current status of trial NCT07356479?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-10-01. Estimated completion is 2031-09-30.
What interventions are being tested in trial NCT07356479?
The interventions under investigation include: EBQI Booster (EBQI/B) (BEHAVIORAL), EBQI Booster + External Facilitation (EBQI/B+EF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07356479?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07356479's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI